Scarica l'app Stockscreener
3.73
10.12%
-0.42
Pre-mercato:
3.78
0.05
+1.34%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché CABA Giù?
Forum
Previsione
Cabaletta Bio Inc Borsa (CABA) Ultime notizie
Global Business Travel Group posts upbeat Q1 results, joins Cabaletta Bio, Aura Biosciences and other big stocks moving higher on Monday - MSN
Number of shareholders of Cabaletta Bio, Inc. – NASDAQ:CABA - TradingView
Number of shareholders of Cabaletta Bio, Inc. – BMV:CABA - TradingView
Guggenheim Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $16 - Moomoo
CABA Stock Pops As $30 Target, Funding And Manufacturing Align - timothysykes.com
Cabaletta, Cellares Sign Manufacturing Deal for Rese-Cel Supply - MyChesCo
Cabaletta Bio prices $150 million public offering - The Pharma Letter
Morgan Stanley Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $13 - Moomoo
CABA Stock On Track For Best Day In 6 Months After Positive Early Results From Cell Therapy Trial - Stocktwits
Cabaletta Bio to Present Rese-Cel Data at ASGCT 2026 Meeting - MyChesCo
Cabaletta Bio | 8-K: Current report - Moomoo
Cabaletta Bio Stock Jumps: Inside the $150 Million Bet on CABA’s Cell Therapy - TechStock²
CABA Reiterates by Cantor Fitzgerald -- Price Target Maintained at $30 - GuruFocus
Cabaletta Bio, Inc. Files Form 8-K with SEC – Company Information, Stock Details, and Compliance Disclosure - Minichart
Cabaletta Bio (CABA) Reports Progress in Pemphigus Vulgaris Trea - GuruFocus
Cabaletta Bio Shares Rise After $150M Underwritten Offering Prices - Moomoo
Guggenheim reiterates Cabaletta Bio stock rating on trial data By Investing.com - Investing.com South Africa
Guggenheim reiterates Cabaletta Bio stock rating on trial data - Investing.com
Global Business Travel Group Posts Upbeat Q1 Results, Joins Cabaletta Bio, Aura Biosciences And Other Big - Benzinga
Cabaletta Bio prices $150 million stock offering at $2.90 - Investing.com UK
Cabaletta Bio prices $150 million stock offering at $2.90 By Investing.com - Investing.com South Africa
Cabaletta Bio Prices $150 Million Stock Offering - Moomoo
Cabaletta Bio stock jumps on $150M offering pricing - Investing.com
Cabaletta Bio stock jumps on $150M offering pricing By Investing.com - Investing.com South Africa
Cabaletta Bio prices $150M stock offering - MSN
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering - The Manila Times
Cabaletta Bio Announces $150 Million Equity Offering - TipRanks
Cabaletta Bio (NASDAQ: CABA) raises $150M via 51.7M-share offering - Stock Titan
Cabaletta Bio (NASDAQ: CABA) prices $150M equity raise to fund rese-cel - Stock Titan
Backed by Eli Lilly, Cabaletta sells $150M in new shares - Stock Titan
Cabaletta Bio (NASDAQ: CABA) to share new rese-cel RESET-PV data at ASGCT 2026 - Stock Titan
Cabaletta Bio, Inc. $CABA Shares Bought by Jennison Associates LLC - MarketBeat
CABA News | CABALETTA BIO INC (NASDAQ:CABA) - ChartMill
Stock Traders Buy High Volume of Call Options on Cabaletta Bio (NASDAQ:CABA) - MarketBeat
H.C. Wainwright reiterates Cabaletta Bio stock rating on manufacturing scalability - Investing.com Australia
Cabaletta Bio enters agreement with California company to manufacture one of its cell therapies - Pennsylvania Business Report -
H.C. Wainwright Maintains Cabaletta Bio(CABA.US) With Buy Rating, Maintains Target Price $16 - Moomoo
Cellares, Cabaletta Bio sign 10-year manufacturing deal for rese-cel - Investing.com UK
Cellares, Cabaletta Bio Ink 10-Year Commercial Supply Pact for Investigational CAR-T Therapy - Contract Pharma
Cellares and Cabaletta Bio Sign 10-Year Commercial Supply Agreement to Scale Rese-cel - BioSpace
Cabaletta Bio signs 10-year manufacturing deal with Cellares By Investing.com - Investing.com South Africa
CABA Forms Agreement with Cellares for Cost-Effective Cell Thera - GuruFocus
CABA Gains Strategic Partnership for Efficient Rese-Cel Producti - GuruFocus
Cabaletta Bio | DEF 14A: Definitive information statements - Moomoo
Cabaletta Bio signs 10-year manufacturing deal with Cellares - Investing.com
1.77%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):